RE: https://newsie.social/@STAT/116369440554418902
"A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope
Once-divisive ‘exon-skipping’ treatments for Duchenne muscular dystrophy are showing startling promise"
By Jason Mast
April 8, 2026
LinkedIn past tracker wall: